🇺🇸 FDA
Pipeline program

mRNA-1647, Sodium Chloride 0.9%, Solution for Injection

mRNA1647-P301

Phase 3 small_molecule active

Quick answer

mRNA-1647, Sodium Chloride 0.9%, Solution for Injection for Cytomegalovirus Infection (CMV) is a Phase 3 program (small_molecule) at Moderna Biotech Spain with 1 ClinicalTrials.gov record(s).

Program details

Company
Moderna Biotech Spain
Indication
Cytomegalovirus Infection (CMV)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials